BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34847838)

  • 1. Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation.
    Qu M; Li J; Yuan L
    Bioengineered; 2021 Dec; 12(2):12940-12953. PubMed ID: 34847838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homoharringtonine inhibits fibroblasts proliferation, extracellular matrix production and reduces surgery-induced knee arthrofibrosis via PI3K/AKT/mTOR pathway-mediated apoptosis.
    Sun Y; Dai J; Jiao R; Jiang Q; Wang J
    J Orthop Surg Res; 2021 Jan; 16(1):9. PubMed ID: 33407698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homoharringtonine suppresses LoVo cell growth by inhibiting EphB4 and the PI3K/AKT and MAPK/EKR1/2 signaling pathways.
    Shi X; Zhu M; Gong Z; Yang T; Yu R; Wang J; Zhang Y
    Food Chem Toxicol; 2020 Feb; 136():110960. PubMed ID: 31726078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
    Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homoharringtonine inhibits the progression of hepatocellular carcinoma by suppressing the PI3K/AKT/GSK3β/Slug signaling pathway.
    Liu HY; Dong TX; Li ZZ; Li TT; Jiang J; Zhu MW; An TT; Chen YD; Yang XH
    Neoplasma; 2021 Sep; 68(5):924-937. PubMed ID: 33998239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homoharringtonine inhibited breast cancer cells growth via miR-18a-3p/AKT/mTOR signaling pathway.
    Wang LB; Wang DN; Wu LG; Cao J; Tian JH; Liu R; Ma R; Yu JJ; Wang J; Huang Q; Xiong WY; Zhang X
    Int J Biol Sci; 2021; 17(4):995-1009. PubMed ID: 33867824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blockage of mTOR signaling pathway by homoharringtonine inhibits proliferation and induces apoptosis of HT29 human colorectal tumor cells].
    Wang D; Tao W; Zhang X; You P; Mu X; Cao J; Li X; Wang L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Apr; 34(4):346-353. PubMed ID: 29973326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Network Pharmacology and Experimental Validation to Study the Action and Mechanism of Water extract of Asparagus Against Colorectal Cancer.
    Liang H; Li Y; Wang F; Zhao J; Yang X; Wu D; Zhang C; Liu Y; Huang J; Su M; He Z; Liu Y; Wang J; Tang D
    Front Pharmacol; 2022; 13():862966. PubMed ID: 35774597
    [No Abstract]   [Full Text] [Related]  

  • 13. Deoxyshikonin isolated from
    Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
    Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
    [No Abstract]   [Full Text] [Related]  

  • 14. Homoharringtonine induces apoptosis of mammary carcinoma cells by inhibiting the AKT/mTOR signaling pathway.
    Zhang X; Mei C; Liang Z; Zhi Y; Xu H; Wang H; Dong H
    Vet Comp Oncol; 2024 Mar; 22(1):57-69. PubMed ID: 38081660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.
    Zhang R; Lian Y; Xie K; Cai Y; Pan Y; Zhu Y
    Bioengineered; 2021 Dec; 12(2):9162-9173. PubMed ID: 34696683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach.
    Wang Y; Zhao T; Huang C; Liu F; Zhang Y; Kong D; Fan Z
    Phytomedicine; 2024 Jan; 123():155174. PubMed ID: 38039904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
    Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
    Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
    Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
    Yin F; Huang X; Xuan Y
    Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.